Pillar Pacific Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Pillar Pacific Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$23.9M	Sell	52,277 -205	-0.4%	-$97.8K	1.85%	6
2020 Q4	$24.4M	Sell	52,482 -726	-1%	-$340K	2.04%	5
2020 Q3	$23.5M	Buy	53,208 +178	+0.3%	+$73.5K	2.24%	4
2020 Q2	$19.2M	Sell	53,030 -816	-2%	-$274K	2.03%	4
2020 Q1	$15.3M	Sell	53,846 -1,751	-3%	-$552K	2.01%	5
2019 Q4	$18.1M	Sell	55,597 -1,126	-2%	-$341K	1.85%	5
2019 Q3	$16.5M	Sell	56,723 -1,581	-3%	-$453K	1.86%	6
2019 Q2	$17.1M	Buy	58,304 +717	+1%	+$197K	1.91%	6
2019 Q1	$15.8M	Sell	57,587 -1,218	-2%	-$303K	1.82%	6
2018 Q4	$13.2M	Sell	58,805 -378	-0.6%	-$88.7K	1.73%	6
2018 Q3	$14.4M	Buy	59,183 +146	+0.2%	+$33.6K	1.56%	6
2018 Q2	$12.2M	Sell	59,037 -106	-0.2%	-$22.5K	1.41%	6
2018 Q1	$12.2M	Buy	59,143 +858	+1%	+$180K	1.46%	8
2017 Q4	$11.1M	Buy	58,285 +40	+0.1%	+$7.66K	1.35%	6
2017 Q3	$11M	Sell	58,245 -485	-0.8%	-$87.8K	1.42%	5
2017 Q2	$10.2M	Buy	58,730 +40	+0.1%	+$6.72K	1.4%	5
2017 Q1	$9.01M	Buy	58,690 +1,410	+2%	+$216K	1.28%	9
2016 Q4	$8.08M	Buy	57,280 +565	+1%	+$83.3K	1.24%	10
2016 Q3	$9.02M	Sell	56,715 -1,213	-2%	-$187K	1.42%	4
2016 Q2	$8.56M	Buy	57,928 +173	+0.3%	+$25.5K	1.44%	3
2016 Q1	$8.18M	Buy	57,755 +774	+1%	+$104K	1.42%	5
2015 Q4	$8.08M	Sell	56,981 -860	-1%	-$115K	1.45%	7
2015 Q3	$7.07M	Buy	57,841 +1,535	+3%	+$200K	1.33%	11
2015 Q2	$7.31M	Buy	56,306 +260	+0.5%	+$33.9K	1.26%	10
2015 Q1	$7.53M	Buy	56,046 +1,003	+2%	+$129K	1.32%	11
2014 Q4	$6.9M	Sell	55,043 -650	-1%	-$79K	1.24%	14
2014 Q3	$6.78M	Buy	55,693 +1,120	+2%	+$136K	1.24%	11
2014 Q2	$6.44M	Buy	54,573 +1,780	+3%	+$209K	1.21%	12
2014 Q1	$6.35M	Sell	52,793 -2,360	-4%	-$281K	1.29%	8
2013 Q4	$6.14M	Sell	55,153 -1,255	-2%	-$125K	1.22%	10
2013 Q3	$5.2M	Buy	56,408 +840	+2%	+$76K	1.15%	13
2013 Q2	$4.7M	Buy	+55,568	New	+$4.63M	1.12%	15

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pillar Pacific Capital Management's TMO Position: Q1 2021 in Review

Pillar Pacific Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 0.39% in Q1 2021, selling an estimated $97.8K and leaving 52,277 shares worth $23.9M. The position accounts for 1.85% of the portfolio, ranked #6.

Pillar Pacific Capital Management first reported a position in TMO in Q2 2013 and has held it in 32 quarters since. The position peaked at $24.4M in Q4 2020. 2,041 funds tracked by Wall St. Rank hold TMO as of Q1 2021.

Pillar Pacific Capital Management held 52,277 shares of Thermo Fisher Scientific worth $23.9M as of Q1 2021.
Pillar Pacific Capital Management sold 205 Thermo Fisher Scientific shares in Q1 2021, an estimated $97.8K.
Thermo Fisher Scientific made up 1.85% of Pillar Pacific Capital Management's portfolio in Q1 2021, its #6 holding.
Pillar Pacific Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 32 quarters since.
Pillar Pacific Capital Management's Thermo Fisher Scientific position peaked at $24.4M in Q4 2020.
2,041 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2021.

Based on Pillar Pacific Capital Management's 13F filing for Q1 2021, filed 4 May 2021.